LacriJet is FCI's latest and exclusive preloaded and self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration. It consists of a single use injector handpiece into which a silicone tube is preloaded inside a metallic guide. LacriJet has been specifically designed to reduce operating time in both the intubation phase and the removal of the device. LacriJet is first introduced into the nasolacrimal duct. Once in position, the sliding piston is retracted and the silicone intubation is released. It is maintained in place at the punctum by a plug-like fixation head. No nasal retrieval, knots or sutures are needed. The 15 mm and 20 mm LacriJet have been specifically designed for canalicular laceration repair to prevent future canalicular obstruction due to scar tissue formation.
